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Endocrine Disorders: Principles of Management

Perioperative Management of Diabetes
Gary W. Edelson, MD,* J. David Fachnie, MD,* and Fred W. Whitehouse, MD'

D

iabetes affects frora 2% to 5% of the American population.
Diabetic patients are more likely to undergo surgery during their lifetirae than are people without diabetes because of an
increased risk of infections, as well as vascular, ocular, and renal
disease. Morbidity andraortalityrates during the perioperative
period are higher in diabetic patients because of a heightened incidence of coronary artery disease, the frequency of impaired renal function, and the propensity to fluid and electrolyte imbalance. Furtherraore, hypoglyceraia can directly affect perioperativeraorbidity,and persistent hyperglyceraia raay increase the
risk of postoperative infections and poor wound healing. Consequentiy, perioperative management of the diabetic patient is a
common, challenging problem. By effectively stabilizing the diabetic state, the risks related to surgery can be minimized and
perioperative outcorae iraproved.
Airas for perioperative control of the blood glucose level
in the diabetic patient include: 1) avoidance of hyperglyceraia
(blood glucose levels over 250 mg/dL with intravenous dextrose
infusing or over 200 mg/dL measured just before oral nourishment), and 2) prevention of hypoglyceraia (blood glucose levels
below 100 mg/dL with intravenous dextro.se infusing or below
80rag/dLmeasured just before oral nourishment). Other usual
raarkers for diabetes control including levels of hemoglobin
A,^, plasma lipids, or urinary glucose are irrelevant during periods of short-terra stress; however, significant ketosis should be
avoided by adequate use of insulin and carbohydrate.
Traditionally, patients have beenraanagedby receiving 50%
of their usual raoming dose of intermediate-acting (NPH or
Lente) insulin on the moming of surgery and then using subcutaneous regular insulin on a sliding-scale basis (guided by raonitored blood glucose levels) along with an intravenous infusion
of 5% dextrose and water. At tiraes no interraediate insulin is
given; instead, intermittent regular insulin is used alone in an
amount related to the monitored blood glucose level and the estimated degree of insulin sensitivity.
A better understanding of the physiologic responses in diabetic patients to the stress of surgery has led to the incorporation
of protocols which utilize an interraediate-acting insulin concomitant with continuous intravenous regular insulin infusions
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at a dose sufficient to blunt the effect of the counter-regulatoiy
hormones. Such management, as well as the use of accurate reflectance meters for blood glucose raonitoring, will lessen m
lability of the diabetes control. The blood glucose concentration
is now easier to stabilize, the incidence of ketoacidosis and undetected hypoglycemia has significantiy decreased, and, as aid
suit, perioperativeraorbidityandraortalityrates have improved.
The following general principles and specific protocols w i
help the practitioner care for diabetic patients in the periopeiative period and during labor and delivery.
L General Principles
A. Most patients scheduled for elective surgery will undergo
medical clearance preoperatively. At that tirae, the state of the
diabetes control will be assessed.
B. Goals for clearance for elective surgery are:
1. Fasting blood glucose below 150 rag/dL.
2. No syraptoras of uncontrolled diabetes.
3. General anabolic state.
C. If these goals are not raet, elective surgery raay be postponed until the diabetes israorestable.
D. Under eraergency surgical situations, stabilization ofthe
diabetes can be achieved proraptly, although diabetic ketoacid""
sis should be treated for several hours in order to correct the metabolic acidosis prior to surgery. Only an exsanguinating hemof'
rhage or equally emergent situation would take precedence.
IL Noninsulin-Requiring Diabetes
A. Minor Surgery
I . For patients with diet-controlled diabetes:
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a) The fasting blood glucose should be less than 150 rag/ required by the patient during those days. Of the total daily dose
of insulin, give two-thirds of the dose in the morning before
j ^ - if ti"^' ''^8'" insulin therapy preoperatively. (See section
breakfast and one-third in the evening before dinner. Of that inII A.3.)
b) Begin an intravenous infusion of 5% dextrose and wa- sulin used in theraomingand in the evening, give two-thirds as
to deliver 6 graras of glucose per hour (120raL/hr)or 100 to an intermediate-acting insulin and one-third as regular insulin.
Exaraple: An average of 36 units of sliding-scale insulin are
',50 grams of glucose per 24 hours.
used daily. To institute araixedregular and interraediate insulin
c) Check the blood glucose every two hours during surregiraen,
give 24 units of insulin in the moming (8 units regular
ety Ifthe blood glucose exceeds 200 mg/dL, then give insulin.
with
16
units
of NPH) and give 12 units of insulin before dinner
(See section 1I.A.3.)
(4
units
regular
with 8 units of NPH).
d) Check the blood glucose every two to four hours after
rsery until it is stable and thenraeasurea daily fasting blood
glucose thereafter.
i n . Insulin-Requiring Diabetes
e) Resurae the usual diet when appropriate.
A. All Operations
2. For patients taking an oral hypoglycemic agent:
1. Stabilize the blood glucose prior to surgery as well as
a) Hold the sulfonylurea on the day of surgery.
possible.
b) The fasting blood glucose should be below 150 mg/
2. Advise the patient to inject the usual daily dose of insulin
if noti begin insulin therapy preoperatively. (See section
on the day prior to the planned operation.
II.A.3.)
3. Adrainister one-half of the usual total daily dose of insuc) Begin an intravenous infusion of 5% dextrose and walin as interraediate (NPH, Lente) insulin in equal araounts every
ter to deliver 6 grams of glucose per hour (120 mL/hr) or 100 to
12 hours on the day of surgery.
150 graras of glucose per 24 hours.
4. Prior to the surgery, begin an intravenous solution cond) Check the blood glucose every two hours during surtaining 100 units of regular insuUn dissolved in 500raLof norgery. Ifthe blood glucose exceeds 200rag/dL,then give insulin.
raal saline at 1 to 2 units of insulin (5 to 10raL)per hour. Siraul(See section H.A.3.)
taneously infuse 5% dextrose and water at 120 mL/hr (6 grams
e) Check the blood glucose every two to four hours postglucose/hr).
operatively until it is stable and then measure a daily fasting
5. During surgery check the blood glucose every one to two
blood glucose thereafter.
hours and adjust the intravenous insulin and/or the intravenous
f) Resurae the usual diet and the oral hypoglyceraic
dextrose delivery rate to maintain the blood glucose between
agent when appropriate.
100 to 200rag/dL.Adjust the insulin delivery rate by 0.5 units
3. When insulin therapy is required:
per hour for every 50rag/dLchange in glucose as follows:
Give 5 units of regular insulin subcutaneously for a
blood glucose of 200 to 250rag/dL,plus 1 unit of regular insuUn
Insulin (U/hr)
Blood Glucose (mg/dL)
0
<80
for every 50rag/dLblood glucose over 250rag/dL.For subse81-100
0.5
quent blood glucoses give regular insulin by this same formula
I0I-1.S0
1.11
as follows: less than 80 rag/dL 0 units; 80 to 120 rag/dL 2
151-200
\.5
units; 121 to 150 rag/dL3 units; 151 to 200rag/dL^ 4 units;
201-250
1.0
201 to 250 rag/dL 5 units; 251 to 300 mg/dL -> 6 units; etc.
251-300
2.5
301-350
3.0
Example: For a blood glucose of 282 rag/dL, initially give 6
351-400
3.5
units of regular insulin subcutaneously followed by regular in4,i)
401-4.50
sulin based on the outlined scale noraoreoften than every four
hours. Absolute amounts of regular insulin given should be ad6. Postoperatively, the above protocol can be continued in
justed as one observes the response of the blood glucose to the
the recovery roora and in an intensive care unit.
initial amounts of insulin.
7. Check the level of serum potassium every four to eight
hours
since an effect of insulin is to lower the serura potassium
B. Major Surgery
level
by
intracellular transfer.
1. Ifthe blood glucose is not controlled (i.e., fasting blood
8. For patients who do not go to an intensive care unit, adglucose is greater than 150 mg/dL), change to intravenous insuminister regular insulin subcutaneously approximately 30 minlin therapy protocol as outiined in section III.A; otherwise folutes before the anticipated completion of surgery or discharge
low the protocol outiined under section II.A.l. or II.A.2.
2. After the operation, when the patient is eating, give sub- from the recovery roora. The intravenous insulin infusion raay
be discontinued 30rainuteslater and the intravenous dextrose
t^utaneous regular insulin on a sliding-scale basis prior to each
infusion rate decreased to 50 to 100 raL/hr.
"leal as suggested above (see section II.A.3.).
9. Conrinue the use of intermittent regular insulin subcuta3. Ifthe patient's total daily insulin requirement exceeds 20
neously
every four to six hours and dextrose intravenously until
''nits for several consecutive days, chronic insulin therapy will
the
patient
tolerates oral intake. Initiate intermediate insuUn as
''kely be needed. Institute a mixture of regular insulin and interthe
patient's
clinical state stabilizes.
'^ediate (NPH, Lente) insulin based upon the amount of insulin
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10. With resuraption of the patient's usual diet, discontinue
the postoperative insulin regiraen and intravenous fluids and
gradually resume the usual insulin regimen.
Note: Diabetic patients should be scheduled for surgery in the
moming whenever possible. However, if surgery later in the day
is anticipated, an altemative manageraent would be to administer a dose of subcutaneous regular insulin on the moming of
surgery dependent on theraonitoredblood glucose and repeated
every four to six hours. Another altemative is the use of onefourth of the total 24-hour insulin dosage as regular insulin
every six hours with adjustments appropriate to the blood glucose response.
IV. Diabetes and Pregnancy: Management for Delivery
Theraetabolicgoal is a blood glucose between 70 to 100 mg/
dL in order to lessen the risk of neonatal hypoglycemia.
A. Diabetes Prior to Pregnancy
1. Women in labor and those scheduled to undergo labor
induction or cesarean section will be fasting.
2. Begin an intravenous infusion of 5% dextrose and onefourth normal saline at 125 to 150 raL/hr.
3. Give one-fourth of the current interraediate-acting (NPH
or Lente) insulin dose on the moming of anticipated delivery.
4. Monitor the blood glucose hourly prior to delivery, immediately postdelivery, and then at least every six hours postpartum.
5. If the blood glucose is greater than 100 mg/dL, begin an
insulin infusion as 100 units of regular insulin dissolved in 500
mL of normal saline at 1 to 2 units of insulin (5 to 10raL)per
hour.
6. Adjust the intravenous insulin and dextrose infusion
rates toraaintainthe blood glucose between 70 to 100 rag/dL
throughout labor and delivery.
7. Discontinue both the insulin and dextrose infusions
when the patient is tolerating oral intake, then adrainister onehalf the prepartura sliding-scale regular insulin subcutaneously
every six hours appropriate to theraonitoredblood glucose.
8. In preparation for discharge, discuss raetabolic goals
with the patient. She raay be placed back on her prepregnancy
insulin regimen unless judged otherwise.
B. Gestational Diabetes Mellitus (diabetes first identified
during this pregnancy)
1. Women in labor and those scheduled to undergo labor
induction or cesarean section will be allowed no oral intake.
2. Begin an intravenous infusion of 5% dextrose and onefourth norraal saline at 125 to 150 raL/hr.
3. Since the patient was not taking insulin prior to pregnancy, intermediate-acting insulin is not routinely given prior to
deUvery. However, it may be necessary in some severe cases of
gestational diabetes mellitus.
4. Administer one-half the prepartura sliding-scale dose of
regular insulin every four to six hours based on the blood glucose level until delivery of the baby. If any blood glucose level
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is greater than 100 rag/dL, initiate treatment with a simulta
neous intravenous insulin infusion (see section IV.A.).
5. Discontinue the intravenous infusions postpartum when
appropriate.
6. Although no further postpartum insulin will be required
in raost patients, some will require it. Therefore, blood glucose
should beraonitoredclosely for 48 hours postpartura.
V. General Observations
1. Sepsis always increases insulin requirement.
2. Slender diabetic patients are more sensitive to insulin than
are obese diabetic patients.
3. Patients undergoing coronary artery bypass surgery or renai transplant surgery usually require larger amounts of insulin
than do patients who undergo other operations.
4. If diabetic ketoacidosis is present prior to surgery, all but
the most emergent operations should be delayed for approximately 6 to 12 hours, if possible, to allow time for control of the
ketoacidotic state.
5. Diabetic patients should be scheduled for surgery in thc
moming whenever possible.
VI. Case Examples
Patient A is a thin, insulin-dependent diabeticraalescheduled
to undergo an appendectomy. He usually takes 4 units of regular
insulin with 20 units of NPH insulin in the moming and 6 units
of regular insulin with 10 units of NPH insulin before dinner.
His blood glucose control is fair with a hemoglobin Ai^, level under 10.0%. On the day of surgery, oral intake is withheld. His
blood glucose is 150mg/dL. He is given lOunits ofNPH insulin
subcutaneously, and a 5% dextrose and water infusion at IM
raL/hr is started along with a siraultaneous insulin infusion at 1
unit/hr (see section III.A.). His blood glucose is raonitored
hourly and appropriate action taken:
Time
1 hr
2hr

Blood Glucose
140 mg/dL
200 mg/dL

3hr

75 mg/dL

4hr

160 mg/dL

5hr

260 mg/dL

6hr

145 mg/dL

10 hr

240 mg/dL

Action
Conlinue the initial infusion.
Increase the insulin rale lo
deliver 1.5 U/hr,
Discontinue the insulin drip and
increase the dextrose infusion
rate to 150 mL/hr,
Resume the insulin infusion at
1,5 U/hr.
Increase the insulin delivery rate
to 2,5 U/hr,
Patient is now in the recovery room,
awake and alert, able lo lake some
sips of liquid. Decrease the dextrose
delivery rate to 75 mL/hr. Give 10
units of NPH insulin subcutaneously
and discontinue the intravenous
insulin 30 minuies later.
Administer 6 units of regular insulin
subcutaneously, Conlinue slidmg-s'^^
regular insulin every four lo six
hours (see section ILA,3,).

al(
Patient B, an obese (approximately 120 kg [264 '^^^j^^g^
with a gangrenous ulcer of the foot, is scheduled to un
femoral-popliteal bypass surgery. He has been requinng
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. of fcgtilar insulin and 50 units of NPH insulin in the raom^ and 20 units of regular insulin and 40 units of NPH insulin
''^f re dinner. On theraomingof surgery he is allowed no food
''^fluids orally and his blood glucose is 310 mg/dL.
*^\dminister 25 units of NPH insulin subcutaneously.
Start 5% dextrose and water at 120 mL/hr intravenously.
Start an intravenous insulin infusion at 3.0 units/hr (see section IH-A-)-

I

His blood glucose is monitored houriy and appropriate actton
taken:

Time
Ihr

' "isulin than

Blood Glucose
200 mg/dL
70 mg/dL

2hr
125 mg/dL
3hr

Action
Decrease insulin infusion rate to
deliver 1.5 U/hr.
Increase intravenous fluid infusion
rate to 150 mL/hr and decrease the
insulin infusion rale to 1.0 U/hr,
Continue intravenous insulin infusion
at 1,0 U/hr,

This pattem can be continued throughout the operation and
carried over into the surgical intensive care unit until the patient
can tolerate oral intake.

lie:
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